Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gastroesophageal Reflux | 245 | 2021 | 318 | 30.760 |
Why?
|
Esophagus | 207 | 2019 | 303 | 17.470 |
Why?
|
Manometry | 183 | 2021 | 276 | 12.420 |
Why?
|
Esophageal Motility Disorders | 50 | 2021 | 59 | 9.980 |
Why?
|
Proton Pump Inhibitors | 55 | 2019 | 91 | 9.590 |
Why?
|
Esophageal Achalasia | 57 | 2021 | 78 | 7.830 |
Why?
|
Electric Impedance | 51 | 2018 | 131 | 7.690 |
Why?
|
Deglutition | 57 | 2019 | 221 | 6.470 |
Why?
|
Gastric Acid | 49 | 2017 | 71 | 6.400 |
Why?
|
Omeprazole | 45 | 2019 | 53 | 5.930 |
Why?
|
Hydrogen-Ion Concentration | 125 | 2017 | 618 | 5.280 |
Why?
|
Anti-Ulcer Agents | 37 | 2008 | 47 | 5.000 |
Why?
|
Esophagogastric Junction | 105 | 2010 | 118 | 4.920 |
Why?
|
Deglutition Disorders | 62 | 2021 | 297 | 4.680 |
Why?
|
Chest Pain | 45 | 2019 | 151 | 4.010 |
Why?
|
Esophageal Diseases | 64 | 2008 | 95 | 3.660 |
Why?
|
Esophageal pH Monitoring | 21 | 2018 | 27 | 3.620 |
Why?
|
Cough | 16 | 2018 | 65 | 3.440 |
Why?
|
Gastric Acidity Determination | 54 | 2017 | 62 | 3.380 |
Why?
|
Monitoring, Ambulatory | 33 | 2008 | 84 | 3.160 |
Why?
|
Barrett Esophagus | 17 | 2018 | 57 | 3.150 |
Why?
|
Humans | 562 | 2021 | 68618 | 3.020 |
Why?
|
Esophagitis, Peptic | 26 | 2020 | 33 | 2.990 |
Why?
|
Catheterization | 37 | 2016 | 209 | 2.980 |
Why?
|
Histamine H2 Antagonists | 24 | 2015 | 45 | 2.880 |
Why?
|
Heartburn | 40 | 2019 | 46 | 2.830 |
Why?
|
Middle Aged | 251 | 2021 | 21147 | 2.630 |
Why?
|
Gastrointestinal Agents | 15 | 2019 | 51 | 2.600 |
Why?
|
Adult | 272 | 2019 | 21403 | 2.450 |
Why?
|
Male | 320 | 2021 | 37321 | 2.400 |
Why?
|
Female | 276 | 2019 | 38074 | 2.250 |
Why?
|
Pharynx | 26 | 2009 | 89 | 2.130 |
Why?
|
Pressure | 98 | 2016 | 252 | 2.010 |
Why?
|
Peristalsis | 67 | 2015 | 76 | 1.990 |
Why?
|
Gastrointestinal Motility | 30 | 2010 | 52 | 1.990 |
Why?
|
Esophageal Spasm, Diffuse | 9 | 2018 | 13 | 1.980 |
Why?
|
Posture | 21 | 2015 | 107 | 1.930 |
Why?
|
Aged | 154 | 2019 | 14862 | 1.910 |
Why?
|
Enzyme Inhibitors | 17 | 2006 | 659 | 1.720 |
Why?
|
Esophageal Sphincter, Lower | 8 | 2019 | 22 | 1.520 |
Why?
|
Ranitidine | 9 | 2015 | 16 | 1.520 |
Why?
|
Fundoplication | 12 | 2019 | 27 | 1.510 |
Why?
|
Monitoring, Physiologic | 30 | 2008 | 219 | 1.480 |
Why?
|
Circadian Rhythm | 16 | 2005 | 218 | 1.440 |
Why?
|
Dilatation | 11 | 2019 | 58 | 1.440 |
Why?
|
Aged, 80 and over | 46 | 2016 | 4848 | 1.260 |
Why?
|
Muscle Contraction | 29 | 2012 | 210 | 1.190 |
Why?
|
Retrospective Studies | 44 | 2019 | 7277 | 1.180 |
Why?
|
Time Factors | 49 | 2019 | 4655 | 1.160 |
Why?
|
Reference Values | 31 | 2008 | 579 | 1.160 |
Why?
|
Esophagoscopy | 24 | 2018 | 72 | 1.150 |
Why?
|
Muscle, Smooth | 31 | 2007 | 117 | 1.100 |
Why?
|
Sleep | 6 | 2015 | 263 | 1.080 |
Why?
|
Adolescent | 55 | 2016 | 8912 | 1.030 |
Why?
|
Botulinum Toxins | 5 | 2018 | 18 | 1.020 |
Why?
|
Severity of Illness Index | 16 | 2018 | 1851 | 1.010 |
Why?
|
Supine Position | 6 | 2015 | 11 | 0.990 |
Why?
|
Esophagitis | 13 | 2004 | 45 | 0.940 |
Why?
|
Antacids | 23 | 2020 | 26 | 0.930 |
Why?
|
Gastroenterology | 6 | 2016 | 98 | 0.920 |
Why?
|
Postprandial Period | 7 | 2009 | 21 | 0.900 |
Why?
|
Plant Oils | 3 | 2019 | 31 | 0.880 |
Why?
|
Cross-Over Studies | 19 | 2015 | 260 | 0.870 |
Why?
|
Gastric Juice | 20 | 2012 | 27 | 0.840 |
Why?
|
Treatment Outcome | 26 | 2019 | 7029 | 0.800 |
Why?
|
Gastrointestinal Transit | 7 | 2012 | 16 | 0.800 |
Why?
|
Double-Blind Method | 30 | 2015 | 1738 | 0.790 |
Why?
|
Larynx | 2 | 2018 | 49 | 0.780 |
Why?
|
Diagnosis, Differential | 28 | 2015 | 1140 | 0.780 |
Why?
|
Nonprescription Drugs | 2 | 2017 | 28 | 0.780 |
Why?
|
Sensitivity and Specificity | 20 | 2016 | 1753 | 0.770 |
Why?
|
Bethanechol | 9 | 2009 | 11 | 0.760 |
Why?
|
2-Pyridinylmethylsulfinylbenzimidazoles | 19 | 2016 | 23 | 0.760 |
Why?
|
Plethysmography, Impedance | 6 | 2012 | 17 | 0.710 |
Why?
|
Long Term Adverse Effects | 1 | 2019 | 6 | 0.700 |
Why?
|
Laryngopharyngeal Reflux | 3 | 2017 | 5 | 0.690 |
Why?
|
Pain | 21 | 1997 | 472 | 0.690 |
Why?
|
Barium Sulfate | 10 | 2016 | 66 | 0.690 |
Why?
|
Pharyngeal Diseases | 5 | 2012 | 21 | 0.670 |
Why?
|
Drug Therapy, Combination | 15 | 2019 | 649 | 0.660 |
Why?
|
Eating | 10 | 2005 | 119 | 0.630 |
Why?
|
Drug Administration Schedule | 15 | 2018 | 567 | 0.620 |
Why?
|
Stomach | 11 | 2006 | 80 | 0.620 |
Why?
|
Asthma | 9 | 2011 | 345 | 0.600 |
Why?
|
Pain Threshold | 7 | 1998 | 55 | 0.600 |
Why?
|
Polyps | 1 | 2017 | 12 | 0.590 |
Why?
|
Laparoscopy | 5 | 2013 | 237 | 0.590 |
Why?
|
Symptom Assessment | 1 | 2017 | 33 | 0.590 |
Why?
|
Lansoprazole | 15 | 2004 | 16 | 0.590 |
Why?
|
Sulfoxides | 4 | 2006 | 16 | 0.590 |
Why?
|
Prospective Studies | 25 | 2018 | 3705 | 0.580 |
Why?
|
Delphi Technique | 1 | 2017 | 62 | 0.570 |
Why?
|
Stomach Neoplasms | 1 | 2017 | 64 | 0.570 |
Why?
|
Thorax | 13 | 1987 | 49 | 0.560 |
Why?
|
Benzimidazoles | 4 | 2006 | 128 | 0.540 |
Why?
|
Follow-Up Studies | 20 | 2016 | 3259 | 0.540 |
Why?
|
Gastrins | 19 | 1997 | 27 | 0.520 |
Why?
|
Gastric Mucosa | 13 | 1999 | 77 | 0.520 |
Why?
|
Peptic Ulcer | 8 | 2005 | 37 | 0.520 |
Why?
|
Digestive System Surgical Procedures | 1 | 2015 | 30 | 0.500 |
Why?
|
Oropharynx | 6 | 2012 | 20 | 0.490 |
Why?
|
Neuromuscular Agents | 1 | 2015 | 22 | 0.490 |
Why?
|
Food | 7 | 2005 | 52 | 0.490 |
Why?
|
Scleroderma, Systemic | 9 | 2007 | 446 | 0.480 |
Why?
|
Gastric Emptying | 13 | 2004 | 24 | 0.480 |
Why?
|
Contrast Media | 5 | 2016 | 595 | 0.480 |
Why?
|
Radiography | 25 | 2015 | 572 | 0.470 |
Why?
|
Hydrochloric Acid | 11 | 1998 | 19 | 0.470 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 438 | 0.470 |
Why?
|
Prevalence | 8 | 2018 | 1619 | 0.460 |
Why?
|
Fiber Optic Technology | 3 | 2013 | 40 | 0.450 |
Why?
|
Predictive Value of Tests | 7 | 2018 | 1465 | 0.450 |
Why?
|
Fasting | 9 | 2006 | 75 | 0.430 |
Why?
|
Intubation, Gastrointestinal | 6 | 2000 | 48 | 0.430 |
Why?
|
Young Adult | 13 | 2016 | 5717 | 0.430 |
Why?
|
Obesity | 4 | 2020 | 1076 | 0.410 |
Why?
|
Administration, Oral | 12 | 2009 | 411 | 0.400 |
Why?
|
Clinical Competence | 2 | 2016 | 657 | 0.400 |
Why?
|
Esomeprazole | 4 | 2006 | 9 | 0.390 |
Why?
|
Mentha piperita | 3 | 2019 | 6 | 0.390 |
Why?
|
Sleep Wake Disorders | 1 | 2012 | 94 | 0.390 |
Why?
|
Hernia, Hiatal | 7 | 2005 | 18 | 0.390 |
Why?
|
Chronic Disease | 20 | 2009 | 1330 | 0.390 |
Why?
|
Probability | 6 | 2008 | 245 | 0.380 |
Why?
|
Risk Assessment | 7 | 2017 | 2007 | 0.380 |
Why?
|
Viscosity | 6 | 2013 | 72 | 0.380 |
Why?
|
Bethanechol Compounds | 20 | 1987 | 20 | 0.370 |
Why?
|
Diagnostic Techniques, Digestive System | 3 | 2007 | 6 | 0.370 |
Why?
|
Evoked Potentials, Somatosensory | 3 | 1999 | 12 | 0.370 |
Why?
|
Parkinson Disease | 3 | 2001 | 272 | 0.370 |
Why?
|
Mentors | 1 | 2011 | 81 | 0.370 |
Why?
|
Endoscopy, Digestive System | 4 | 2017 | 78 | 0.360 |
Why?
|
Analysis of Variance | 12 | 2012 | 1040 | 0.360 |
Why?
|
Career Choice | 1 | 2011 | 98 | 0.360 |
Why?
|
Serotonin Receptor Agonists | 2 | 2009 | 34 | 0.350 |
Why?
|
Baclofen | 3 | 2019 | 24 | 0.350 |
Why?
|
Alginates | 6 | 2020 | 35 | 0.350 |
Why?
|
Cohort Studies | 8 | 2008 | 2358 | 0.340 |
Why?
|
Gastrointestinal Hemorrhage | 4 | 2005 | 185 | 0.340 |
Why?
|
Edrophonium | 15 | 1994 | 15 | 0.340 |
Why?
|
Prodrugs | 1 | 2009 | 54 | 0.340 |
Why?
|
Risk Factors | 13 | 2016 | 5731 | 0.340 |
Why?
|
Teaching | 1 | 2011 | 169 | 0.340 |
Why?
|
Cimetidine | 13 | 1995 | 25 | 0.330 |
Why?
|
Laryngitis | 3 | 1999 | 12 | 0.330 |
Why?
|
Pyridostigmine Bromide | 1 | 2009 | 11 | 0.330 |
Why?
|
Phosphodiesterase Inhibitors | 2 | 2006 | 28 | 0.330 |
Why?
|
Dose-Response Relationship, Drug | 19 | 2009 | 1745 | 0.330 |
Why?
|
Buspirone | 1 | 2009 | 36 | 0.330 |
Why?
|
Neurotransmitter Agents | 1 | 2009 | 102 | 0.320 |
Why?
|
Equipment Design | 6 | 2015 | 500 | 0.310 |
Why?
|
Laryngeal Diseases | 3 | 2011 | 22 | 0.310 |
Why?
|
Antidepressive Agents, Tricyclic | 2 | 2018 | 45 | 0.310 |
Why?
|
Dyspareunia | 1 | 2008 | 7 | 0.310 |
Why?
|
Subclavian Artery | 2 | 2021 | 30 | 0.310 |
Why?
|
Anti-Dyskinesia Agents | 2 | 1999 | 3 | 0.300 |
Why?
|
Esophageal Neoplasms | 8 | 2017 | 150 | 0.300 |
Why?
|
Calcium Channel Blockers | 5 | 2018 | 138 | 0.300 |
Why?
|
Sensation | 6 | 1998 | 49 | 0.300 |
Why?
|
Electrodes | 7 | 2003 | 147 | 0.300 |
Why?
|
Indoles | 2 | 2006 | 146 | 0.300 |
Why?
|
Mechanoreceptors | 3 | 1997 | 11 | 0.300 |
Why?
|
Reproducibility of Results | 9 | 2013 | 2077 | 0.300 |
Why?
|
Recurrence | 7 | 2019 | 948 | 0.290 |
Why?
|
Eosinophilic Esophagitis | 2 | 2019 | 5 | 0.290 |
Why?
|
Muscarinic Agonists | 1 | 2007 | 17 | 0.290 |
Why?
|
Chemoreceptor Cells | 2 | 1997 | 5 | 0.290 |
Why?
|
Aluminum Hydroxide | 2 | 2020 | 3 | 0.290 |
Why?
|
Sodium Bicarbonate | 2 | 2020 | 5 | 0.290 |
Why?
|
Silicic Acid | 2 | 2020 | 4 | 0.290 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2006 | 100 | 0.280 |
Why?
|
Nifedipine | 5 | 1992 | 40 | 0.280 |
Why?
|
Feeding Behavior | 4 | 2005 | 224 | 0.280 |
Why?
|
Proton-Translocating ATPases | 1 | 2006 | 9 | 0.280 |
Why?
|
Age Factors | 11 | 2013 | 1864 | 0.270 |
Why?
|
Dyspepsia | 2 | 1999 | 8 | 0.270 |
Why?
|
Hypopharynx | 2 | 2004 | 2 | 0.270 |
Why?
|
Ambulatory Care | 8 | 2007 | 340 | 0.270 |
Why?
|
Single-Blind Method | 6 | 2012 | 249 | 0.260 |
Why?
|
Carbolines | 1 | 2005 | 19 | 0.260 |
Why?
|
Sex Factors | 8 | 2013 | 1266 | 0.260 |
Why?
|
Beverages | 2 | 2005 | 50 | 0.260 |
Why?
|
South Carolina | 3 | 2018 | 2752 | 0.260 |
Why?
|
Surveys and Questionnaires | 9 | 2019 | 2800 | 0.260 |
Why?
|
Evoked Potentials | 4 | 1996 | 61 | 0.260 |
Why?
|
Child | 12 | 2011 | 6405 | 0.260 |
Why?
|
Duodenogastric Reflux | 2 | 1996 | 2 | 0.250 |
Why?
|
Sensory Thresholds | 4 | 1999 | 50 | 0.250 |
Why?
|
Esophageal Sphincter, Upper | 3 | 2009 | 7 | 0.250 |
Why?
|
Life Style | 5 | 2005 | 338 | 0.250 |
Why?
|
ROC Curve | 3 | 2012 | 392 | 0.250 |
Why?
|
Imidazoles | 1 | 2005 | 175 | 0.250 |
Why?
|
Feeding and Eating Disorders of Childhood | 1 | 2004 | 1 | 0.240 |
Why?
|
Myoelectric Complex, Migrating | 1 | 2004 | 2 | 0.240 |
Why?
|
Statistics, Nonparametric | 6 | 2007 | 306 | 0.240 |
Why?
|
Disease Progression | 4 | 2017 | 1038 | 0.240 |
Why?
|
Piperazines | 1 | 2005 | 206 | 0.230 |
Why?
|
Voice Disorders | 1 | 2004 | 22 | 0.230 |
Why?
|
Helicobacter Infections | 1 | 2004 | 40 | 0.230 |
Why?
|
Gastrointestinal Diseases | 4 | 1997 | 107 | 0.230 |
Why?
|
Angina Pectoris | 4 | 1992 | 61 | 0.230 |
Why?
|
Helicobacter pylori | 1 | 2004 | 54 | 0.230 |
Why?
|
Recovery of Function | 2 | 2019 | 506 | 0.220 |
Why?
|
Aging | 7 | 1998 | 911 | 0.220 |
Why?
|
Diet | 7 | 2003 | 514 | 0.220 |
Why?
|
GABA Agonists | 1 | 2003 | 23 | 0.220 |
Why?
|
Chi-Square Distribution | 5 | 2008 | 546 | 0.210 |
Why?
|
Proton Pumps | 2 | 2000 | 13 | 0.210 |
Why?
|
Eructation | 3 | 1998 | 3 | 0.210 |
Why?
|
Cisapride | 2 | 1999 | 4 | 0.210 |
Why?
|
Incidence | 6 | 2008 | 1603 | 0.210 |
Why?
|
Muscle Relaxation | 5 | 2004 | 31 | 0.210 |
Why?
|
Famotidine | 1 | 2002 | 1 | 0.210 |
Why?
|
Prostheses and Implants | 5 | 1997 | 159 | 0.210 |
Why?
|
Wound Healing | 2 | 2002 | 260 | 0.210 |
Why?
|
Risk Reduction Behavior | 1 | 2003 | 174 | 0.200 |
Why?
|
Case-Control Studies | 6 | 2008 | 1553 | 0.200 |
Why?
|
Disease Management | 1 | 2003 | 248 | 0.200 |
Why?
|
Menstrual Cycle | 2 | 1999 | 64 | 0.200 |
Why?
|
Medical History Taking | 3 | 2015 | 94 | 0.190 |
Why?
|
Cardiovascular Abnormalities | 1 | 2021 | 15 | 0.190 |
Why?
|
Drug Combinations | 2 | 2020 | 304 | 0.190 |
Why?
|
Sucralfate | 4 | 1988 | 4 | 0.190 |
Why?
|
Infant | 6 | 2007 | 2891 | 0.190 |
Why?
|
Lewy Bodies | 1 | 2001 | 7 | 0.190 |
Why?
|
Endoscopy, Gastrointestinal | 4 | 2008 | 171 | 0.190 |
Why?
|
Food-Drug Interactions | 1 | 2000 | 4 | 0.190 |
Why?
|
Spasm | 11 | 1995 | 18 | 0.180 |
Why?
|
Animals | 41 | 2003 | 20881 | 0.180 |
Why?
|
Dilatation, Pathologic | 2 | 2016 | 58 | 0.180 |
Why?
|
Video Recording | 2 | 1998 | 145 | 0.180 |
Why?
|
Parasympatholytics | 6 | 2006 | 19 | 0.180 |
Why?
|
Bile | 2 | 2017 | 35 | 0.180 |
Why?
|
Treatment Failure | 3 | 2008 | 216 | 0.170 |
Why?
|
Transducers, Pressure | 6 | 2008 | 14 | 0.170 |
Why?
|
Luteinizing Hormone | 1 | 1999 | 31 | 0.170 |
Why?
|
Dicyclomine | 1 | 1999 | 1 | 0.170 |
Why?
|
Prostaglandins | 5 | 1982 | 65 | 0.170 |
Why?
|
Cardia | 2 | 1998 | 4 | 0.170 |
Why?
|
Sex Distribution | 3 | 2008 | 274 | 0.170 |
Why?
|
Cholinergic Antagonists | 1 | 1999 | 17 | 0.170 |
Why?
|
Electrodiagnosis | 3 | 2012 | 12 | 0.170 |
Why?
|
Software | 4 | 2015 | 418 | 0.160 |
Why?
|
Age Distribution | 3 | 2008 | 320 | 0.160 |
Why?
|
Octreotide | 1 | 1999 | 21 | 0.160 |
Why?
|
Radionuclide Imaging | 13 | 1990 | 166 | 0.160 |
Why?
|
Choristoma | 1 | 1998 | 20 | 0.160 |
Why?
|
Transducers | 8 | 2005 | 21 | 0.160 |
Why?
|
Progesterone | 2 | 1999 | 115 | 0.160 |
Why?
|
Conversion Disorder | 1 | 1998 | 2 | 0.160 |
Why?
|
Microcomputers | 5 | 1991 | 32 | 0.160 |
Why?
|
Mucous Membrane | 9 | 2000 | 66 | 0.160 |
Why?
|
Cats | 11 | 1998 | 292 | 0.160 |
Why?
|
Nitroglycerin | 3 | 2006 | 20 | 0.160 |
Why?
|
Imipramine | 1 | 1998 | 44 | 0.160 |
Why?
|
Barium Radioisotopes | 1 | 2018 | 3 | 0.160 |
Why?
|
Isosorbide Dinitrate | 1 | 2018 | 6 | 0.160 |
Why?
|
Terminology as Topic | 2 | 2018 | 141 | 0.160 |
Why?
|
Adenocarcinoma | 3 | 2017 | 475 | 0.160 |
Why?
|
Myotomy | 1 | 2018 | 14 | 0.150 |
Why?
|
Pirenzepine | 4 | 1992 | 17 | 0.150 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2018 | 25 | 0.150 |
Why?
|
Complementary Therapies | 1 | 2018 | 43 | 0.150 |
Why?
|
Pilot Projects | 2 | 2019 | 1342 | 0.150 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2005 | 931 | 0.150 |
Why?
|
Nitric Oxide Donors | 1 | 2018 | 54 | 0.150 |
Why?
|
Computers | 4 | 1987 | 63 | 0.150 |
Why?
|
Muscles | 5 | 1986 | 158 | 0.150 |
Why?
|
Societies, Medical | 2 | 2003 | 403 | 0.150 |
Why?
|
Receptors, Histamine H2 | 2 | 1988 | 4 | 0.150 |
Why?
|
Piperidines | 1 | 1998 | 123 | 0.150 |
Why?
|
Esophageal Stenosis | 5 | 1990 | 36 | 0.150 |
Why?
|
Documentation | 1 | 2018 | 83 | 0.150 |
Why?
|
Supranuclear Palsy, Progressive | 1 | 1997 | 6 | 0.150 |
Why?
|
Esophageal Mucosa | 1 | 2017 | 2 | 0.140 |
Why?
|
Drug Resistance | 4 | 2019 | 223 | 0.140 |
Why?
|
Precision Medicine | 1 | 2018 | 111 | 0.140 |
Why?
|
Combined Modality Therapy | 3 | 2015 | 951 | 0.140 |
Why?
|
Sex Characteristics | 2 | 1998 | 295 | 0.140 |
Why?
|
United States | 7 | 2019 | 7367 | 0.140 |
Why?
|
Liver Cirrhosis | 13 | 1976 | 301 | 0.140 |
Why?
|
Respiratory Tract Diseases | 2 | 1988 | 43 | 0.140 |
Why?
|
Dietary Fats | 8 | 1996 | 103 | 0.140 |
Why?
|
Intestinal Mucosa | 4 | 2004 | 219 | 0.140 |
Why?
|
Child, Preschool | 4 | 2007 | 3187 | 0.140 |
Why?
|
Metoclopramide | 9 | 1987 | 21 | 0.140 |
Why?
|
Learning Curve | 1 | 2016 | 20 | 0.140 |
Why?
|
Diphosphonates | 1 | 1996 | 39 | 0.140 |
Why?
|
Benzodiazepinones | 2 | 1986 | 4 | 0.140 |
Why?
|
Pepsin A | 2 | 2011 | 8 | 0.140 |
Why?
|
Muscle Tonus | 4 | 1992 | 9 | 0.140 |
Why?
|
Hoarseness | 3 | 2011 | 6 | 0.130 |
Why?
|
Acetylcholine Release Inhibitors | 1 | 2015 | 2 | 0.130 |
Why?
|
Observer Variation | 2 | 2015 | 330 | 0.130 |
Why?
|
Pregnancy Complications | 2 | 1998 | 286 | 0.130 |
Why?
|
Body Mass Index | 2 | 2012 | 867 | 0.130 |
Why?
|
Botulinum Toxins, Type A | 1 | 2015 | 31 | 0.130 |
Why?
|
Pain Measurement | 1 | 1996 | 328 | 0.130 |
Why?
|
Papio | 9 | 1985 | 27 | 0.130 |
Why?
|
Cacao | 4 | 1988 | 11 | 0.130 |
Why?
|
Medical Staff, Hospital | 1 | 2015 | 44 | 0.130 |
Why?
|
Guanidines | 3 | 1980 | 32 | 0.130 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2018 | 446 | 0.120 |
Why?
|
History, 20th Century | 2 | 2010 | 248 | 0.120 |
Why?
|
Prostaglandins E | 4 | 1982 | 54 | 0.120 |
Why?
|
Tertiary Care Centers | 1 | 2015 | 67 | 0.120 |
Why?
|
Bicarbonates | 4 | 1992 | 21 | 0.120 |
Why?
|
Referral and Consultation | 1 | 1997 | 383 | 0.120 |
Why?
|
Cytokines | 1 | 2019 | 866 | 0.120 |
Why?
|
Retreatment | 3 | 2006 | 59 | 0.120 |
Why?
|
Dietary Fats, Unsaturated | 1 | 1993 | 8 | 0.110 |
Why?
|
Cardiovascular Diseases | 2 | 2002 | 940 | 0.110 |
Why?
|
Artifacts | 2 | 2013 | 125 | 0.110 |
Why?
|
Monoamine Oxidase | 4 | 1976 | 26 | 0.110 |
Why?
|
Sucrose | 1 | 1993 | 58 | 0.110 |
Why?
|
Practice Patterns, Physicians' | 1 | 2018 | 504 | 0.110 |
Why?
|
Percussion | 5 | 1979 | 5 | 0.110 |
Why?
|
Health Personnel | 1 | 2016 | 286 | 0.110 |
Why?
|
Running | 2 | 1990 | 20 | 0.110 |
Why?
|
Electrophysiology | 2 | 2005 | 160 | 0.110 |
Why?
|
Triglycerides | 1 | 1993 | 184 | 0.110 |
Why?
|
Pentagastrin | 12 | 1983 | 16 | 0.110 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 1990 | 240 | 0.110 |
Why?
|
Consciousness | 1 | 2012 | 17 | 0.110 |
Why?
|
Injections | 2 | 2006 | 119 | 0.110 |
Why?
|
Students, Medical | 1 | 2015 | 210 | 0.110 |
Why?
|
Actigraphy | 1 | 2012 | 28 | 0.110 |
Why?
|
Quality of Health Care | 1 | 2015 | 322 | 0.110 |
Why?
|
Vagus Nerve | 3 | 1992 | 90 | 0.110 |
Why?
|
Fatty Acids | 1 | 1993 | 222 | 0.110 |
Why?
|
Random Allocation | 7 | 2015 | 442 | 0.100 |
Why?
|
Propantheline | 3 | 1987 | 3 | 0.100 |
Why?
|
Saliva | 1 | 1993 | 142 | 0.100 |
Why?
|
Zenker Diverticulum | 1 | 1992 | 7 | 0.100 |
Why?
|
Aorta, Thoracic | 1 | 1994 | 211 | 0.100 |
Why?
|
Cranial Nerve Neoplasms | 1 | 1992 | 13 | 0.100 |
Why?
|
Stimulation, Chemical | 7 | 2001 | 57 | 0.100 |
Why?
|
Endoscopy | 10 | 2005 | 464 | 0.100 |
Why?
|
Patient Satisfaction | 1 | 2015 | 378 | 0.100 |
Why?
|
Neurilemmoma | 1 | 1992 | 26 | 0.100 |
Why?
|
Diltiazem | 3 | 1991 | 26 | 0.100 |
Why?
|
Rectum | 2 | 1990 | 62 | 0.100 |
Why?
|
Area Under Curve | 1 | 2012 | 238 | 0.100 |
Why?
|
Linear Models | 1 | 2013 | 521 | 0.100 |
Why?
|
Quality of Life | 6 | 2019 | 1515 | 0.090 |
Why?
|
Abdominal Pain | 1 | 1992 | 97 | 0.090 |
Why?
|
Duodenal Ulcer | 5 | 1981 | 16 | 0.090 |
Why?
|
Ulcer | 3 | 1997 | 27 | 0.090 |
Why?
|
Brain | 2 | 1992 | 2176 | 0.090 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2013 | 237 | 0.090 |
Why?
|
Computer Systems | 2 | 1990 | 42 | 0.090 |
Why?
|
Proctitis | 1 | 1990 | 2 | 0.090 |
Why?
|
Evaluation Studies as Topic | 7 | 1989 | 219 | 0.090 |
Why?
|
Overweight | 1 | 2012 | 186 | 0.090 |
Why?
|
Radiation Injuries, Experimental | 1 | 1990 | 22 | 0.090 |
Why?
|
Laser Therapy | 1 | 1990 | 54 | 0.090 |
Why?
|
Clinical Trials as Topic | 11 | 1995 | 848 | 0.090 |
Why?
|
Prognosis | 2 | 2013 | 2093 | 0.090 |
Why?
|
Prostaglandins E, Synthetic | 2 | 1988 | 5 | 0.090 |
Why?
|
Disease-Free Survival | 2 | 2003 | 349 | 0.090 |
Why?
|
Ammonia | 8 | 1971 | 28 | 0.090 |
Why?
|
Reflex, Abnormal | 1 | 1989 | 6 | 0.090 |
Why?
|
Algorithms | 4 | 2006 | 1196 | 0.090 |
Why?
|
Epoprostenol | 4 | 1982 | 71 | 0.090 |
Why?
|
Heart Diseases | 2 | 2000 | 276 | 0.090 |
Why?
|
Gastrointestinal Hormones | 5 | 1979 | 5 | 0.080 |
Why?
|
Lung | 1 | 1994 | 849 | 0.080 |
Why?
|
Airway Obstruction | 1 | 1989 | 49 | 0.080 |
Why?
|
Disease Models, Animal | 5 | 1992 | 2550 | 0.080 |
Why?
|
Biopsy | 4 | 2016 | 540 | 0.080 |
Why?
|
Physical Exertion | 1 | 1989 | 75 | 0.080 |
Why?
|
Velopharyngeal Sphincter | 1 | 2008 | 7 | 0.080 |
Why?
|
Fluoroscopy | 3 | 2008 | 152 | 0.080 |
Why?
|
Cholinesterase Inhibitors | 1 | 2009 | 58 | 0.080 |
Why?
|
Neuroglia | 1 | 2009 | 136 | 0.080 |
Why?
|
Regression Analysis | 3 | 2008 | 737 | 0.080 |
Why?
|
Autoimmunity | 1 | 2009 | 118 | 0.080 |
Why?
|
Coitus | 1 | 2008 | 12 | 0.080 |
Why?
|
Drug Tolerance | 1 | 2008 | 80 | 0.080 |
Why?
|
Salivation | 2 | 1987 | 7 | 0.080 |
Why?
|
Gastroscopy | 2 | 2008 | 45 | 0.080 |
Why?
|
Sickness Impact Profile | 1 | 2008 | 27 | 0.080 |
Why?
|
Vagotomy | 4 | 1976 | 9 | 0.080 |
Why?
|
Aminophylline | 1 | 1987 | 2 | 0.070 |
Why?
|
Terbutaline | 1 | 1987 | 23 | 0.070 |
Why?
|
Pregnancy | 5 | 1999 | 2334 | 0.070 |
Why?
|
Anemia, Pernicious | 4 | 1975 | 11 | 0.070 |
Why?
|
Preoperative Care | 2 | 2001 | 275 | 0.070 |
Why?
|
Water | 6 | 2007 | 230 | 0.070 |
Why?
|
Infusions, Parenteral | 6 | 1985 | 47 | 0.070 |
Why?
|
Internship and Residency | 1 | 2013 | 596 | 0.070 |
Why?
|
Education, Medical, Continuing | 1 | 2008 | 136 | 0.070 |
Why?
|
Cerebral Cortex | 1 | 1990 | 415 | 0.070 |
Why?
|
Autoantibodies | 1 | 2009 | 434 | 0.070 |
Why?
|
Ascites | 2 | 1982 | 38 | 0.070 |
Why?
|
Parasympathomimetics | 3 | 1976 | 13 | 0.070 |
Why?
|
Receptors, Histamine | 1 | 1986 | 3 | 0.070 |
Why?
|
Verapamil | 2 | 1985 | 30 | 0.070 |
Why?
|
Food Hypersensitivity | 2 | 1978 | 20 | 0.070 |
Why?
|
Vardenafil Dihydrochloride | 1 | 2005 | 2 | 0.070 |
Why?
|
Tadalafil | 1 | 2005 | 4 | 0.070 |
Why?
|
Biopolymers | 1 | 2006 | 21 | 0.070 |
Why?
|
Dosage Forms | 1 | 2005 | 20 | 0.070 |
Why?
|
Isoenzymes | 3 | 1976 | 308 | 0.070 |
Why?
|
Parietal Cells, Gastric | 1 | 2005 | 23 | 0.070 |
Why?
|
Sildenafil Citrate | 1 | 2005 | 23 | 0.070 |
Why?
|
Acids | 4 | 1997 | 12 | 0.070 |
Why?
|
Epithelium | 2 | 2001 | 172 | 0.070 |
Why?
|
Purines | 1 | 2005 | 39 | 0.070 |
Why?
|
Macaca mulatta | 8 | 1988 | 77 | 0.070 |
Why?
|
Health Care Costs | 2 | 2001 | 346 | 0.070 |
Why?
|
Sulfones | 1 | 2005 | 45 | 0.070 |
Why?
|
Lidocaine | 1 | 1985 | 36 | 0.060 |
Why?
|
Hypertension, Portal | 5 | 1978 | 53 | 0.060 |
Why?
|
Powders | 1 | 2005 | 32 | 0.060 |
Why?
|
Disposable Equipment | 1 | 2005 | 12 | 0.060 |
Why?
|
Ultrasonography | 4 | 1993 | 453 | 0.060 |
Why?
|
Liver | 4 | 1979 | 1118 | 0.060 |
Why?
|
Triazines | 1 | 2005 | 48 | 0.060 |
Why?
|
Vasodilator Agents | 1 | 2006 | 138 | 0.060 |
Why?
|
Behavior Therapy | 3 | 2018 | 297 | 0.060 |
Why?
|
Endosonography | 1 | 2006 | 177 | 0.060 |
Why?
|
Diabetic Neuropathies | 3 | 1985 | 33 | 0.060 |
Why?
|
Placebos | 3 | 1997 | 195 | 0.060 |
Why?
|
Liver Circulation | 5 | 1969 | 40 | 0.060 |
Why?
|
Antidepressive Agents | 1 | 2006 | 216 | 0.060 |
Why?
|
Hyperplasia | 3 | 1990 | 89 | 0.060 |
Why?
|
Pneumonia, Aspiration | 2 | 1985 | 22 | 0.060 |
Why?
|
Urban Health | 1 | 2004 | 49 | 0.060 |
Why?
|
Data Interpretation, Statistical | 2 | 2008 | 329 | 0.060 |
Why?
|
Benzazepines | 1 | 1984 | 104 | 0.060 |
Why?
|
Indomethacin | 4 | 1988 | 107 | 0.060 |
Why?
|
Interviews as Topic | 1 | 2005 | 392 | 0.060 |
Why?
|
Bloodletting | 1 | 1983 | 1 | 0.060 |
Why?
|
Polycythemia | 1 | 1983 | 3 | 0.060 |
Why?
|
False Positive Reactions | 3 | 1993 | 95 | 0.060 |
Why?
|
Lung Diseases, Obstructive | 1 | 1983 | 20 | 0.060 |
Why?
|
Hodgkin Disease | 2 | 1981 | 27 | 0.050 |
Why?
|
Hexuronic Acids | 3 | 1991 | 24 | 0.050 |
Why?
|
Glucuronic Acid | 3 | 1991 | 25 | 0.050 |
Why?
|
Diverticulum, Esophageal | 1 | 1982 | 4 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2005 | 1046 | 0.050 |
Why?
|
Haplorhini | 9 | 1984 | 44 | 0.050 |
Why?
|
Drug Interactions | 2 | 2002 | 289 | 0.050 |
Why?
|
Bilirubin | 3 | 2004 | 51 | 0.050 |
Why?
|
Methacholine Compounds | 3 | 1976 | 7 | 0.050 |
Why?
|
Patient Selection | 1 | 2006 | 592 | 0.050 |
Why?
|
Central Nervous System Diseases | 1 | 1982 | 40 | 0.050 |
Why?
|
Dogs | 3 | 1990 | 490 | 0.050 |
Why?
|
Cold Temperature | 1 | 1981 | 90 | 0.050 |
Why?
|
Activities of Daily Living | 1 | 2003 | 319 | 0.050 |
Why?
|
Reaction Time | 2 | 1993 | 170 | 0.050 |
Why?
|
Body Weight | 5 | 1994 | 554 | 0.050 |
Why?
|
Therapeutic Equivalency | 1 | 2001 | 21 | 0.050 |
Why?
|
Hyperthermia, Induced | 1 | 2002 | 53 | 0.050 |
Why?
|
Lymphoma | 1 | 1982 | 116 | 0.050 |
Why?
|
Weight Loss | 2 | 1996 | 319 | 0.050 |
Why?
|
Physical Examination | 1 | 1982 | 152 | 0.050 |
Why?
|
Agranulocytosis | 1 | 1980 | 15 | 0.050 |
Why?
|
Barium | 2 | 1997 | 52 | 0.050 |
Why?
|
Drug Synergism | 1 | 2001 | 260 | 0.050 |
Why?
|
Periodicity | 1 | 2001 | 43 | 0.050 |
Why?
|
Neural Inhibition | 1 | 1981 | 80 | 0.050 |
Why?
|
Postoperative Period | 1 | 2001 | 238 | 0.050 |
Why?
|
Eosinophilia | 1 | 1980 | 47 | 0.050 |
Why?
|
Respiratory Function Tests | 2 | 1994 | 123 | 0.050 |
Why?
|
Neutropenia | 1 | 1980 | 72 | 0.050 |
Why?
|
Gastric Fundus | 2 | 1990 | 8 | 0.040 |
Why?
|
Famous Persons | 1 | 1980 | 15 | 0.040 |
Why?
|
Anorexia Nervosa | 2 | 1979 | 52 | 0.040 |
Why?
|
Blood Circulation Time | 2 | 1978 | 3 | 0.040 |
Why?
|
Consensus | 1 | 2021 | 211 | 0.040 |
Why?
|
Quality Indicators, Health Care | 1 | 2021 | 136 | 0.040 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 1999 | 22 | 0.040 |
Why?
|
Thrombocytopenia | 1 | 1980 | 122 | 0.040 |
Why?
|
Hemodynamics | 2 | 1985 | 705 | 0.040 |
Why?
|
Remission, Spontaneous | 2 | 1999 | 25 | 0.040 |
Why?
|
Acute Disease | 3 | 1998 | 658 | 0.040 |
Why?
|
Desipramine | 1 | 2019 | 47 | 0.040 |
Why?
|
Prone Position | 1 | 1999 | 8 | 0.040 |
Why?
|
Muscle Relaxants, Central | 1 | 2019 | 13 | 0.040 |
Why?
|
Pyloric Antrum | 3 | 1976 | 10 | 0.040 |
Why?
|
Liver Diseases | 4 | 1977 | 193 | 0.040 |
Why?
|
Microfilament Proteins | 1 | 1999 | 102 | 0.040 |
Why?
|
Interleukin-23 | 1 | 2019 | 13 | 0.040 |
Why?
|
Metaplasia | 1 | 1999 | 27 | 0.040 |
Why?
|
Nutrition Disorders | 1 | 1979 | 16 | 0.040 |
Why?
|
Atropine | 4 | 1987 | 29 | 0.040 |
Why?
|
Hypertension | 3 | 1980 | 1535 | 0.040 |
Why?
|
Smoking | 4 | 1994 | 1452 | 0.040 |
Why?
|
Receptors, Cholinergic | 2 | 1976 | 30 | 0.040 |
Why?
|
Interleukins | 1 | 2019 | 79 | 0.040 |
Why?
|
Chlorpheniramine | 1 | 1978 | 1 | 0.040 |
Why?
|
Analog-Digital Conversion | 1 | 1998 | 2 | 0.040 |
Why?
|
Cell Division | 1 | 1999 | 541 | 0.040 |
Why?
|
Interleukin-17 | 1 | 2019 | 62 | 0.040 |
Why?
|
Air | 1 | 1998 | 22 | 0.040 |
Why?
|
Interleukin-12 | 1 | 2019 | 75 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2004 | 767 | 0.040 |
Why?
|
Neural Conduction | 2 | 1977 | 24 | 0.040 |
Why?
|
Acid-Base Imbalance | 1 | 1998 | 3 | 0.040 |
Why?
|
Coronary Disease | 1 | 1980 | 358 | 0.040 |
Why?
|
Histamine | 1 | 1978 | 52 | 0.040 |
Why?
|
Zollinger-Ellison Syndrome | 4 | 1981 | 4 | 0.040 |
Why?
|
Pharyngeal Muscles | 2 | 1995 | 10 | 0.040 |
Why?
|
California | 1 | 2018 | 99 | 0.040 |
Why?
|
Decision Trees | 1 | 2018 | 74 | 0.040 |
Why?
|
Auscultation | 1 | 1977 | 4 | 0.040 |
Why?
|
Fatty Liver | 3 | 1967 | 97 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2004 | 2279 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2001 | 442 | 0.040 |
Why?
|
Interferon-gamma | 1 | 2019 | 241 | 0.040 |
Why?
|
Biomarkers | 2 | 2019 | 1593 | 0.040 |
Why?
|
Gastrectomy | 2 | 1975 | 24 | 0.040 |
Why?
|
Calibration | 1 | 1997 | 73 | 0.040 |
Why?
|
Abdomen | 1 | 1977 | 80 | 0.040 |
Why?
|
Digestive System Neoplasms | 1 | 1997 | 13 | 0.040 |
Why?
|
Peripheral Nerves | 1 | 1977 | 22 | 0.040 |
Why?
|
Selection Bias | 1 | 1997 | 23 | 0.040 |
Why?
|
Systole | 2 | 1992 | 149 | 0.040 |
Why?
|
Hyperalgesia | 1 | 1997 | 18 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2019 | 330 | 0.040 |
Why?
|
Capsules | 1 | 1997 | 18 | 0.040 |
Why?
|
Sleep Stages | 1 | 1997 | 30 | 0.040 |
Why?
|
Viscera | 1 | 1997 | 16 | 0.040 |
Why?
|
Sensory Receptor Cells | 1 | 1996 | 9 | 0.040 |
Why?
|
Alendronate | 1 | 1996 | 4 | 0.040 |
Why?
|
Delayed-Action Preparations | 1 | 1997 | 120 | 0.040 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 1996 | 20 | 0.040 |
Why?
|
Ion-Selective Electrodes | 1 | 1996 | 2 | 0.040 |
Why?
|
Inflammatory Bowel Diseases | 1 | 1997 | 59 | 0.030 |
Why?
|
Mouth Neoplasms | 1 | 1979 | 206 | 0.030 |
Why?
|
Safety | 1 | 1997 | 145 | 0.030 |
Why?
|
Carrier Proteins | 1 | 1999 | 597 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2021 | 445 | 0.030 |
Why?
|
Blood Pressure | 4 | 1992 | 1451 | 0.030 |
Why?
|
Body Height | 2 | 1994 | 67 | 0.030 |
Why?
|
Perfusion | 5 | 1989 | 131 | 0.030 |
Why?
|
Caffeine | 2 | 1975 | 81 | 0.030 |
Why?
|
Electroencephalography | 2 | 1990 | 418 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2019 | 626 | 0.030 |
Why?
|
Eosinophils | 1 | 2016 | 60 | 0.030 |
Why?
|
Withholding Treatment | 1 | 2016 | 35 | 0.030 |
Why?
|
Managed Care Programs | 1 | 1996 | 45 | 0.030 |
Why?
|
False Negative Reactions | 2 | 1989 | 63 | 0.030 |
Why?
|
Portacaval Shunt, Surgical | 3 | 1972 | 5 | 0.030 |
Why?
|
Sialorrhea | 1 | 1995 | 7 | 0.030 |
Why?
|
Alkalies | 3 | 1979 | 6 | 0.030 |
Why?
|
Cell Differentiation | 1 | 1999 | 1034 | 0.030 |
Why?
|
Diagnosis | 2 | 1965 | 15 | 0.030 |
Why?
|
Lymphocytes | 1 | 2016 | 228 | 0.030 |
Why?
|
Evoked Potentials, Motor | 1 | 1995 | 63 | 0.030 |
Why?
|
Videotape Recording | 1 | 1995 | 43 | 0.030 |
Why?
|
Neutrophils | 1 | 2016 | 204 | 0.030 |
Why?
|
Practice Guidelines as Topic | 2 | 1997 | 772 | 0.030 |
Why?
|
Duodenum | 1 | 1975 | 47 | 0.030 |
Why?
|
Hepatitis A | 3 | 1972 | 8 | 0.030 |
Why?
|
Muscular Dystrophies | 1 | 1995 | 17 | 0.030 |
Why?
|
Methods | 5 | 1992 | 156 | 0.030 |
Why?
|
Schistosomiasis | 3 | 1974 | 6 | 0.030 |
Why?
|
Psychophysiologic Disorders | 1 | 1994 | 20 | 0.030 |
Why?
|
Mathematics | 2 | 1991 | 83 | 0.030 |
Why?
|
Silicone Elastomers | 1 | 1994 | 17 | 0.030 |
Why?
|
Rubber | 1 | 1994 | 13 | 0.030 |
Why?
|
Premedication | 2 | 1985 | 49 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 1998 | 396 | 0.030 |
Why?
|
Hemosiderosis | 1 | 1974 | 7 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2015 | 127 | 0.030 |
Why?
|
Opossums | 2 | 1985 | 7 | 0.030 |
Why?
|
Patient Education as Topic | 1 | 1997 | 425 | 0.030 |
Why?
|
Afferent Pathways | 1 | 1993 | 31 | 0.030 |
Why?
|
Splenomegaly | 2 | 1977 | 13 | 0.030 |
Why?
|
Peripheral Nervous System Diseases | 2 | 1988 | 37 | 0.030 |
Why?
|
Pyrazoles | 3 | 1973 | 190 | 0.030 |
Why?
|
Exercise Test | 1 | 1994 | 242 | 0.030 |
Why?
|
Fats | 1 | 1973 | 8 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 1994 | 236 | 0.030 |
Why?
|
History, 19th Century | 1 | 1993 | 95 | 0.030 |
Why?
|
Diagnostic Errors | 2 | 1987 | 100 | 0.030 |
Why?
|
Peptides | 3 | 1976 | 455 | 0.030 |
Why?
|
Respiration | 2 | 1990 | 91 | 0.030 |
Why?
|
Lung Diseases | 1 | 1994 | 175 | 0.030 |
Why?
|
Nociceptors | 1 | 1992 | 9 | 0.030 |
Why?
|
Head | 1 | 1993 | 59 | 0.030 |
Why?
|
Neurofibroma | 1 | 1992 | 11 | 0.030 |
Why?
|
Thoracotomy | 1 | 1992 | 25 | 0.030 |
Why?
|
Veterans | 1 | 2019 | 904 | 0.030 |
Why?
|
Collateral Circulation | 4 | 1969 | 34 | 0.030 |
Why?
|
Peritoneal Cavity | 1 | 1991 | 25 | 0.020 |
Why?
|
Peritoneal Dialysis, Continuous Ambulatory | 1 | 1991 | 14 | 0.020 |
Why?
|
Secretin | 3 | 1979 | 18 | 0.020 |
Why?
|
Colon | 2 | 1974 | 168 | 0.020 |
Why?
|
Food Preferences | 1 | 1991 | 46 | 0.020 |
Why?
|
Thoracic Diseases | 2 | 1982 | 10 | 0.020 |
Why?
|
Ileocecal Valve | 1 | 1970 | 3 | 0.020 |
Why?
|
Research Design | 1 | 2015 | 729 | 0.020 |
Why?
|
Hypoglycemia | 1 | 1971 | 72 | 0.020 |
Why?
|
Butylamines | 1 | 1990 | 2 | 0.020 |
Why?
|
Hepatitis | 3 | 1969 | 25 | 0.020 |
Why?
|
Infusion Pumps | 1 | 1990 | 39 | 0.020 |
Why?
|
Neuromuscular Diseases | 1 | 1990 | 14 | 0.020 |
Why?
|
Esophageal and Gastric Varices | 3 | 1972 | 47 | 0.020 |
Why?
|
Spinal Cord Injuries | 1 | 1996 | 551 | 0.020 |
Why?
|
Supination | 1 | 1990 | 2 | 0.020 |
Why?
|
Solutions | 1 | 1990 | 115 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 1990 | 351 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1990 | 532 | 0.020 |
Why?
|
Beds | 1 | 1989 | 13 | 0.020 |
Why?
|
Scalp | 1 | 1990 | 47 | 0.020 |
Why?
|
Hot Temperature | 1 | 1990 | 152 | 0.020 |
Why?
|
Brain Diseases | 1 | 1990 | 78 | 0.020 |
Why?
|
Radioimmunoprecipitation Assay | 1 | 2009 | 5 | 0.020 |
Why?
|
Weight Lifting | 1 | 1989 | 15 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2009 | 95 | 0.020 |
Why?
|
Emergencies | 1 | 1989 | 107 | 0.020 |
Why?
|
Bicycling | 1 | 1989 | 39 | 0.020 |
Why?
|
Secretory Rate | 2 | 1979 | 11 | 0.020 |
Why?
|
Smoking Prevention | 1 | 1991 | 259 | 0.020 |
Why?
|
Respiratory Sounds | 1 | 2009 | 35 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1993 | 689 | 0.020 |
Why?
|
Portal Vein | 3 | 1978 | 46 | 0.020 |
Why?
|
Dimaprit | 1 | 1988 | 1 | 0.020 |
Why?
|
Photofluorography | 1 | 2008 | 3 | 0.020 |
Why?
|
Thiourea | 1 | 1988 | 16 | 0.020 |
Why?
|
Alcohol Drinking | 2 | 1991 | 805 | 0.020 |
Why?
|
Osteoarthritis | 1 | 1989 | 73 | 0.020 |
Why?
|
Medical Records | 1 | 1989 | 121 | 0.020 |
Why?
|
Hypertension, Renal | 2 | 1965 | 29 | 0.020 |
Why?
|
Plants, Edible | 1 | 1988 | 3 | 0.020 |
Why?
|
Hypertension, Renovascular | 2 | 1965 | 47 | 0.020 |
Why?
|
Dyspnea | 1 | 2009 | 87 | 0.020 |
Why?
|
Body Water | 2 | 1986 | 35 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 1989 | 157 | 0.020 |
Why?
|
Chagas Disease | 1 | 1988 | 8 | 0.020 |
Why?
|
Intestinal Pseudo-Obstruction | 1 | 1988 | 7 | 0.020 |
Why?
|
Insulin | 1 | 1971 | 619 | 0.020 |
Why?
|
Nausea | 2 | 1984 | 47 | 0.020 |
Why?
|
Connective Tissue Diseases | 1 | 1988 | 18 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2008 | 219 | 0.020 |
Why?
|
Bread | 1 | 2007 | 2 | 0.020 |
Why?
|
Gastric Dilatation | 1 | 1967 | 3 | 0.020 |
Why?
|
Homosexuality | 2 | 1965 | 10 | 0.020 |
Why?
|
Leukocytosis | 1 | 1987 | 13 | 0.020 |
Why?
|
Neurotic Disorders | 2 | 1965 | 13 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 507 | 0.020 |
Why?
|
Optical Fibers | 1 | 1987 | 7 | 0.020 |
Why?
|
Sodium | 3 | 1974 | 161 | 0.020 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 1987 | 6 | 0.020 |
Why?
|
Pentetic Acid | 1 | 1987 | 18 | 0.020 |
Why?
|
Radiation Dosage | 1 | 1990 | 419 | 0.020 |
Why?
|
Long-Term Care | 1 | 1987 | 53 | 0.020 |
Why?
|
Biomechanical Phenomena | 1 | 2008 | 368 | 0.020 |
Why?
|
Meprobamate | 1 | 1967 | 1 | 0.020 |
Why?
|
Serum Albumin | 1 | 1967 | 104 | 0.020 |
Why?
|
Coma | 1 | 1967 | 17 | 0.020 |
Why?
|
Hydrostatic Pressure | 1 | 1987 | 11 | 0.020 |
Why?
|
Blotting, Western | 1 | 2009 | 954 | 0.020 |
Why?
|
Precancerous Conditions | 1 | 1987 | 74 | 0.020 |
Why?
|
Online Systems | 1 | 1986 | 20 | 0.020 |
Why?
|
Peritoneal Dialysis | 1 | 1967 | 30 | 0.020 |
Why?
|
Gold Colloid, Radioactive | 1 | 1966 | 1 | 0.020 |
Why?
|
Organometallic Compounds | 1 | 1987 | 95 | 0.020 |
Why?
|
Quaternary Ammonium Compounds | 1 | 1966 | 20 | 0.020 |
Why?
|
Oklahoma | 1 | 2006 | 18 | 0.020 |
Why?
|
Xerostomia | 1 | 1986 | 24 | 0.020 |
Why?
|
Dietary Proteins | 3 | 1975 | 51 | 0.020 |
Why?
|
Drainage | 1 | 1967 | 133 | 0.020 |
Why?
|
Receptors, Muscarinic | 1 | 1986 | 44 | 0.020 |
Why?
|
Diabetes Complications | 1 | 1988 | 249 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 1986 | 134 | 0.020 |
Why?
|
Hydrogen | 1 | 1986 | 35 | 0.020 |
Why?
|
Theophylline | 1 | 1985 | 22 | 0.020 |
Why?
|
Diabetes Insipidus, Nephrogenic | 1 | 1965 | 1 | 0.020 |
Why?
|
Drug Evaluation | 1 | 1985 | 47 | 0.020 |
Why?
|
Demeclocycline | 1 | 1965 | 2 | 0.020 |
Why?
|
Diabetes Insipidus | 1 | 1965 | 5 | 0.020 |
Why?
|
Photosensitivity Disorders | 1 | 1965 | 7 | 0.020 |
Why?
|
Toxicology | 1 | 1965 | 14 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2006 | 334 | 0.020 |
Why?
|
Adrenergic beta-Agonists | 1 | 1985 | 92 | 0.020 |
Why?
|
Vasopressins | 1 | 1965 | 33 | 0.020 |
Why?
|
Liver Diseases, Parasitic | 1 | 1965 | 1 | 0.020 |
Why?
|
Psychotherapy | 2 | 1965 | 253 | 0.020 |
Why?
|
Drug Therapy | 1 | 1965 | 71 | 0.020 |
Why?
|
Blood | 1 | 1965 | 40 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 1994 | 2223 | 0.020 |
Why?
|
Data Collection | 1 | 1986 | 420 | 0.020 |
Why?
|
Menstruation | 1 | 1984 | 20 | 0.020 |
Why?
|
Spectrophotometry, Ultraviolet | 2 | 1975 | 79 | 0.020 |
Why?
|
Intestinal Diseases, Parasitic | 2 | 1974 | 7 | 0.020 |
Why?
|
Intestinal Polyps | 2 | 1974 | 15 | 0.020 |
Why?
|
Transvestism | 1 | 1964 | 2 | 0.010 |
Why?
|
Gonadal Steroid Hormones | 1 | 1984 | 52 | 0.010 |
Why?
|
Cardiac Catheterization | 1 | 1987 | 419 | 0.010 |
Why?
|
Silicones | 1 | 1984 | 32 | 0.010 |
Why?
|
Endocrine Glands | 1 | 1984 | 7 | 0.010 |
Why?
|
Hydralazine | 1 | 1984 | 12 | 0.010 |
Why?
|
Suction | 1 | 1984 | 33 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 1994 | 2324 | 0.010 |
Why?
|
Stomach Diseases | 1 | 1984 | 22 | 0.010 |
Why?
|
Foreign-Body Migration | 1 | 1984 | 38 | 0.010 |
Why?
|
Vegetables | 2 | 1975 | 76 | 0.010 |
Why?
|
Electrocardiography | 1 | 1986 | 601 | 0.010 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 1964 | 88 | 0.010 |
Why?
|
Kidney | 2 | 1965 | 945 | 0.010 |
Why?
|
Depression, Chemical | 2 | 1980 | 29 | 0.010 |
Why?
|
Alprostadil | 1 | 1982 | 20 | 0.010 |
Why?
|
Kinetics | 2 | 1975 | 1047 | 0.010 |
Why?
|
Phobic Disorders | 1 | 1964 | 227 | 0.010 |
Why?
|
Erythrocytes | 1 | 1983 | 137 | 0.010 |
Why?
|
Cell Separation | 1 | 1983 | 132 | 0.010 |
Why?
|
Postoperative Complications | 1 | 1990 | 1615 | 0.010 |
Why?
|
Injections, Subcutaneous | 2 | 1975 | 87 | 0.010 |
Why?
|
Pain Management | 1 | 1984 | 186 | 0.010 |
Why?
|
Neck Muscles | 1 | 1982 | 6 | 0.010 |
Why?
|
Coronary Vessels | 1 | 1985 | 313 | 0.010 |
Why?
|
Kidney Diseases | 1 | 1965 | 307 | 0.010 |
Why?
|
Reoperation | 1 | 1984 | 467 | 0.010 |
Why?
|
Body Composition | 1 | 2003 | 119 | 0.010 |
Why?
|
Self Care | 1 | 2005 | 253 | 0.010 |
Why?
|
Burns, Chemical | 1 | 1982 | 7 | 0.010 |
Why?
|
Rats | 1 | 1990 | 5300 | 0.010 |
Why?
|
Naval Medicine | 2 | 1975 | 8 | 0.010 |
Why?
|
Ice Cream | 1 | 1981 | 1 | 0.010 |
Why?
|
Ion Channels | 1 | 1982 | 72 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 1982 | 193 | 0.010 |
Why?
|
Refractory Period, Electrophysiological | 1 | 1981 | 3 | 0.010 |
Why?
|
Leiomyoma | 1 | 1981 | 28 | 0.010 |
Why?
|
Radiography, Abdominal | 1 | 1982 | 57 | 0.010 |
Why?
|
Vomiting | 1 | 1981 | 56 | 0.010 |
Why?
|
Xenon | 2 | 1972 | 4 | 0.010 |
Why?
|
Blood Vessels | 1 | 1982 | 102 | 0.010 |
Why?
|
Infusions, Intra-Arterial | 1 | 1981 | 27 | 0.010 |
Why?
|
Energy Transfer | 1 | 2001 | 25 | 0.010 |
Why?
|
Radio Waves | 1 | 2001 | 21 | 0.010 |
Why?
|
Health Surveys | 1 | 2003 | 489 | 0.010 |
Why?
|
Liver Function Tests | 2 | 1972 | 114 | 0.010 |
Why?
|
Radioisotopes | 2 | 1972 | 40 | 0.010 |
Why?
|
Peptic Ulcer Hemorrhage | 1 | 1980 | 26 | 0.010 |
Why?
|
Intestine, Small | 1 | 1981 | 89 | 0.010 |
Why?
|
Arbaprostil | 1 | 1980 | 1 | 0.010 |
Why?
|
Prostaglandins F | 1 | 1980 | 13 | 0.010 |
Why?
|
Fever | 1 | 1980 | 96 | 0.010 |
Why?
|
6-Ketoprostaglandin F1 alpha | 1 | 1980 | 42 | 0.010 |
Why?
|
Injections, Intravenous | 2 | 1986 | 215 | 0.010 |
Why?
|
Depressive Disorder | 1 | 1964 | 621 | 0.010 |
Why?
|
Coronary Angiography | 1 | 1985 | 866 | 0.010 |
Why?
|
Phenolsulfonphthalein | 1 | 1979 | 2 | 0.010 |
Why?
|
Dye Dilution Technique | 1 | 1979 | 3 | 0.010 |
Why?
|
Somatostatin | 1 | 1979 | 36 | 0.010 |
Why?
|
Vasoactive Intestinal Peptide | 1 | 1979 | 19 | 0.010 |
Why?
|
Glucagon | 1 | 1979 | 22 | 0.010 |
Why?
|
Wounds, Penetrating | 1 | 1999 | 45 | 0.010 |
Why?
|
Blood Transfusion | 1 | 1980 | 205 | 0.010 |
Why?
|
Anorexia | 1 | 1979 | 7 | 0.010 |
Why?
|
Alcoholism | 1 | 1988 | 1109 | 0.010 |
Why?
|
Parenteral Nutrition, Total | 1 | 1979 | 22 | 0.010 |
Why?
|
Nutritional Physiological Phenomena | 1 | 1979 | 24 | 0.010 |
Why?
|
Pyloric Stenosis | 1 | 1978 | 5 | 0.010 |
Why?
|
Spleen | 2 | 1977 | 301 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2004 | 2455 | 0.010 |
Why?
|
Xenon Radioisotopes | 1 | 1978 | 6 | 0.010 |
Why?
|
Angiography | 2 | 1972 | 194 | 0.010 |
Why?
|
Motor Activity | 1 | 1981 | 621 | 0.010 |
Why?
|
Multiple Sclerosis | 1 | 1979 | 132 | 0.010 |
Why?
|
Sural Nerve | 1 | 1977 | 4 | 0.010 |
Why?
|
Ulnar Nerve | 1 | 1977 | 7 | 0.010 |
Why?
|
Median Nerve | 1 | 1977 | 5 | 0.010 |
Why?
|
Reflex | 1 | 1977 | 21 | 0.010 |
Why?
|
Ketamine | 1 | 1978 | 57 | 0.010 |
Why?
|
Erectile Dysfunction | 1 | 1977 | 22 | 0.010 |
Why?
|
Skin Temperature | 1 | 1977 | 24 | 0.010 |
Why?
|
Rupture | 1 | 1977 | 29 | 0.010 |
Why?
|
Lipids | 1 | 1979 | 298 | 0.010 |
Why?
|
Neurologic Examination | 1 | 1977 | 107 | 0.010 |
Why?
|
Depression | 1 | 1964 | 943 | 0.010 |
Why?
|
Medication Errors | 1 | 1978 | 116 | 0.010 |
Why?
|
Pylorus | 1 | 1976 | 6 | 0.010 |
Why?
|
Hospital Departments | 1 | 1976 | 15 | 0.010 |
Why?
|
Meat | 2 | 1975 | 34 | 0.010 |
Why?
|
Anesthesia | 1 | 1978 | 120 | 0.010 |
Why?
|
Hydroxyapatites | 1 | 1976 | 10 | 0.010 |
Why?
|
Hemochromatosis | 1 | 1976 | 13 | 0.010 |
Why?
|
Nizatidine | 1 | 1995 | 1 | 0.010 |
Why?
|
Chromatography, Ion Exchange | 1 | 1976 | 73 | 0.010 |
Why?
|
Scleroderma, Localized | 1 | 1975 | 19 | 0.010 |
Why?
|
Autonomic Nervous System | 1 | 1975 | 31 | 0.010 |
Why?
|
Spectrophotometry | 1 | 1975 | 54 | 0.010 |
Why?
|
Schistosoma haematobium | 1 | 1974 | 1 | 0.010 |
Why?
|
Schistosoma mansoni | 1 | 1974 | 4 | 0.010 |
Why?
|
Molecular Weight | 1 | 1975 | 358 | 0.010 |
Why?
|
Calcium Carbonate | 1 | 1974 | 7 | 0.010 |
Why?
|
Gastritis | 1 | 1974 | 12 | 0.010 |
Why?
|
Semicarbazides | 1 | 1974 | 1 | 0.010 |
Why?
|
Benzaldehydes | 1 | 1974 | 8 | 0.010 |
Why?
|
Monoamine Oxidase Inhibitors | 1 | 1974 | 30 | 0.010 |
Why?
|
Kynurenic Acid | 1 | 1974 | 26 | 0.010 |
Why?
|
Magnesium | 1 | 1974 | 110 | 0.010 |
Why?
|
Ethylamines | 1 | 1973 | 1 | 0.010 |
Why?
|
Vitamin B 12 | 1 | 1973 | 21 | 0.010 |
Why?
|
Colonic Diseases | 1 | 1974 | 36 | 0.010 |
Why?
|
Temperature | 1 | 1975 | 341 | 0.010 |
Why?
|
Oils | 1 | 1973 | 6 | 0.010 |
Why?
|
Citrus | 1 | 1973 | 12 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1973 | 165 | 0.010 |
Why?
|
Milk | 1 | 1973 | 43 | 0.010 |
Why?
|
Zea mays | 1 | 1973 | 27 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 1974 | 420 | 0.010 |
Why?
|
Proteins | 2 | 1975 | 474 | 0.010 |
Why?
|
Portography | 1 | 1972 | 1 | 0.010 |
Why?
|
Phlebography | 1 | 1972 | 31 | 0.010 |
Why?
|
Glucose Tolerance Test | 1 | 1972 | 75 | 0.010 |
Why?
|
Sodium Chloride | 2 | 1986 | 136 | 0.010 |
Why?
|
Sheep | 1 | 1992 | 128 | 0.010 |
Why?
|
Hormones | 1 | 1972 | 42 | 0.010 |
Why?
|
Vena Cava, Inferior | 1 | 1972 | 41 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 1974 | 299 | 0.010 |
Why?
|
Hernia, Diaphragmatic | 1 | 1971 | 10 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 1977 | 694 | 0.010 |
Why?
|
Appetite | 1 | 1991 | 16 | 0.010 |
Why?
|
Sodium Hydroxide | 1 | 1971 | 5 | 0.010 |
Why?
|
Glucose | 1 | 1972 | 307 | 0.010 |
Why?
|
Cell Membrane Permeability | 1 | 1971 | 59 | 0.010 |
Why?
|
Diffusion | 1 | 1971 | 90 | 0.010 |
Why?
|
Portasystemic Shunt, Surgical | 1 | 1969 | 3 | 0.010 |
Why?
|
Self Medication | 1 | 1989 | 25 | 0.010 |
Why?
|
Caprylates | 1 | 1969 | 32 | 0.010 |
Why?
|
Hepatomegaly | 1 | 1969 | 4 | 0.010 |
Why?
|
Fructose | 1 | 1969 | 51 | 0.010 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 1989 | 75 | 0.000 |
Why?
|
Jejunum | 1 | 1968 | 26 | 0.000 |
Why?
|
Chromium Isotopes | 1 | 1967 | 2 | 0.000 |
Why?
|
Infectious Mononucleosis | 1 | 1967 | 7 | 0.000 |
Why?
|
Suspensions | 1 | 1987 | 11 | 0.000 |
Why?
|
Intestinal Perforation | 1 | 1968 | 35 | 0.000 |
Why?
|
Malaria | 1 | 1967 | 26 | 0.000 |
Why?
|
Intubation | 1 | 1987 | 20 | 0.000 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 1967 | 20 | 0.000 |
Why?
|
Radiotherapy | 1 | 1968 | 86 | 0.000 |
Why?
|
Clinical Enzyme Tests | 1 | 1967 | 6 | 0.000 |
Why?
|
Ethanol | 1 | 1974 | 893 | 0.000 |
Why?
|
Arthritis | 1 | 1987 | 53 | 0.000 |
Why?
|
Primary Myelofibrosis | 1 | 1966 | 3 | 0.000 |
Why?
|
Pheochromocytoma | 1 | 1966 | 22 | 0.000 |
Why?
|
Paraphilic Disorders | 1 | 1965 | 4 | 0.000 |
Why?
|
Urography | 1 | 1964 | 21 | 0.000 |
Why?
|
Patient Compliance | 1 | 1987 | 402 | 0.000 |
Why?
|
Renal Artery Obstruction | 1 | 1964 | 29 | 0.000 |
Why?
|
Kidney Function Tests | 1 | 1964 | 114 | 0.000 |
Why?
|
Nephrectomy | 1 | 1964 | 103 | 0.000 |
Why?
|
Meperidine | 1 | 1983 | 5 | 0.000 |
Why?
|
Surgical Procedures, Operative | 1 | 1964 | 124 | 0.000 |
Why?
|
Estradiol | 1 | 1984 | 176 | 0.000 |
Why?
|
Rest | 1 | 1979 | 78 | 0.000 |
Why?
|
Glycine | 1 | 1979 | 89 | 0.000 |
Why?
|
Models, Biological | 1 | 1981 | 981 | 0.000 |
Why?
|
Niridazole | 1 | 1974 | 1 | 0.000 |
Why?
|
Parasite Egg Count | 1 | 1974 | 5 | 0.000 |
Why?
|
Sigmoidoscopy | 1 | 1974 | 38 | 0.000 |
Why?
|
Radioimmunoassay | 1 | 1974 | 164 | 0.000 |
Why?
|
Sulfobromophthalein | 1 | 1971 | 2 | 0.000 |
Why?
|
Alkaline Phosphatase | 1 | 1971 | 71 | 0.000 |
Why?
|
Aspartate Aminotransferases | 1 | 1971 | 87 | 0.000 |
Why?
|
Alanine Transaminase | 1 | 1971 | 137 | 0.000 |
Why?
|
Administration, Rectal | 1 | 1969 | 26 | 0.000 |
Why?
|
Gold Isotopes | 1 | 1969 | 1 | 0.000 |
Why?
|
Cobalt Isotopes | 1 | 1968 | 1 | 0.000 |
Why?
|
Bone Marrow | 1 | 1969 | 168 | 0.000 |
Why?
|
Intestinal Neoplasms | 1 | 1968 | 30 | 0.000 |
Why?
|
Neoplasm Metastasis | 1 | 1969 | 306 | 0.000 |
Why?
|
Length of Stay | 1 | 1971 | 780 | 0.000 |
Why?
|
In Vitro Techniques | 1 | 1966 | 765 | 0.000 |
Why?
|
Liver Neoplasms | 1 | 1969 | 334 | 0.000 |
Why?
|